Endocrine Abstracts

Introduction: The aim of this study was to determine the prevalence of thyroid dysfunction in Greek patients with type 1 (T1DM) and type 2 (T2DM) diabetes as well as its possible relation to glycemic control and to diabetic complications.Patients and methods: A total of 990 patients (60.7% men) with T1DM or T2DM, consecutively followed in the Outpatient Diabetes Clinic, participated in the study. In every patient anthropometric and biochemical measuremen...

Introduction: The aim of the study is to determine whether the guidelines on glycemic control and cardiovascular risk factors are being followed in everyday clinical practice and to describe the lifestyle habits and the wellbeing of patients with Type1 or Type 2 diabetes.Patients and methods: A total of 990 patients with diabetes consecutively followed in the Outpatient Diabetes Clinic were studied (60.8% men). Clinical and laboratory parameters and livi...

Background: Arterial stiffness is a well-established surrogate marker of vascular properties and arterial dysfunction in patients with type 2 diabetes mellitus (DM2). We aimed to investigate whether optimization of DM2 therapy with, additional to metformin, novel antiglycemic agents may improve arterial wall properties and achieve better glycemic control.Methods: We enrolled 99 consecutive patients (male gender=63.3%) receiving metformin for DM2 who did ...

Background: Patients with type 2 diabetes (T2D) are at higher risk for thrombotic events and as a result cardiovascular disease. Platelet function may be used to assess prothrombotic state in patients with cardiovascular disease.Purpose: We aimed to investigate whether the administration of novel antidiabetic agents influence platelet function in TDM2 patients.Patients and Methods: We 60 enrolled consecutive patients with T2DM, on ...

Introduction: Patients with type 2 diabetes mellitus (T2DM) exert a higher risk for thrombotic events. Platelet reactivity may be used to assess prothrombotic state in such patients. The aim of this study was to investigate whether the administration of novel antidiabetic agents could influence the platelet reactivity in T2DM patients.Patients and methods: We enrolled 99 consecutive patients (males=63.3%), 64.92±8.3 years old, receiving metformin fo...